Fusion Antibodies plc is a Contract Research Organisation (CRO) based in Northern Ireland that specializes in antibody discovery, engineering, and expression services for therapeutic and diagnostic applications. The company provides a comprehensive range of services, including the identification and optimization of antibodies, as well as the production of high-quality antibodies and cGMP-ready manufacturing cell lines. Fusion serves customers in the biopharmaceutical, veterinary, diagnostic, and life sciences sectors, focusing on both human and veterinary therapeutic markets. Its operations extend into various global markets, leveraging advanced technologies to enhance antibody performance and supply continuity.